Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma.
- DOI
- 10.1016/j.bmcl.2020.127763
- Published
- 2021 Feb 15
- Container
- Bioorganic & medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmcl.2020.127763,
title = {Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma.},
author = {Naveen Sadhu M and Sivanandhan D and Gajendran C and Tantry S and Dewang P and Murugan K and Chickamunivenkatappa S and Zainuddin M and Nair S and Vaithilingam K and Rajagopal S},
year = {2021},
journal = {Bioorganic \& medicinal chemistry letters},
doi = {10.1016/j.bmcl.2020.127763},
url = {https://doi.org/10.1016/j.bmcl.2020.127763}
}RIS
TY - JOUR TI - Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma. AU - Naveen Sadhu M AU - Sivanandhan D AU - Gajendran C AU - Tantry S AU - Dewang P AU - Murugan K AU - Chickamunivenkatappa S AU - Zainuddin M AU - Nair S AU - Vaithilingam K AU - Rajagopal S PY - 2021 JO - Bioorganic & medicinal chemistry letters DO - 10.1016/j.bmcl.2020.127763 UR - https://doi.org/10.1016/j.bmcl.2020.127763 ER -
APA
M, N. S., D, S., C, G., S, T., P, D., K, M., S, C., M, Z., S, N., K, V., & S, R. (2021). Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma.. Bioorganic & medicinal chemistry letters. https://doi.org/10.1016/j.bmcl.2020.127763
Source records
- pubmed · retrieved 2026-09-27T08:08:32.535Z